Literature DB >> 19550038

Selection of scFvs specific for the HepG2 cell line using ribosome display.

Lei Zhou1, Wei-Ping Mao, Juan Fen, Hong-Yun Liu, Chuan-Jing Wei, Wen-Xiu Li, Feng-Yun Zhou.   

Abstract

The aim of this study was to construct a ribosome display library of single chain variable fragments (scFvs) associated with hepatocarcinoma and screen such a library for hepatocarcinoma-binding scFvs. mRNA was isolated from the spleens of mice immunized with hepatocellular carcinoma cell line HepG2. Heavy and k chain genes (VH and k) were amplified separately by RT-PCR, and an anti-HepG2 VH/k chain ribosome display library was constructed by assembling VH and k into the VH/k chain with a specially constructed linker by SOE-PCR. The VH/k chain library was transcribed and translated in vitro using a rabbit reticulocyte lysate system. In order to isolate specific scFvs, recognizing HepG2 negative selection on a normal hepatocyte line WRL-68 was carried out before three rounds of positive selection on HepG2. After three rounds of panning, cell enzyme-linked immunosorbent assay (ELISA) showed that one of the scFvs had high affinity for the HepG2 cell and lower affinity for the WRL-68 cell. In this study, we successfully constructed a native ribosome display library. Such a library would prove useful for direct intact cell panning using ribosome display technology. The selected scFv had a potential value for hepatocarcinoma treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550038     DOI: 10.1007/s12038-009-0026-2

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  15 in total

Review 1.  Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics.

Authors:  R A Irving; G Coia; A Roberts; S D Nuttall; P J Hudson
Journal:  J Immunol Methods       Date:  2001-02-01       Impact factor: 2.303

2.  Interferon-induced gene expression and signaling in human hepatoma cell lines.

Authors:  K Melén; P Keskinen; A Lehtonen; I Julkunen
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

3.  Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic system.

Authors:  Mingyue He; Michael J Taussig
Journal:  J Immunol Methods       Date:  2005-01-11       Impact factor: 2.303

4.  ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome.

Authors:  Michael J Taussig; Oda Stoevesandt; Carl A K Borrebaeck; Andrew R Bradbury; Dolores Cahill; Christian Cambillau; Antoine de Daruvar; Stefan Dübel; Jutta Eichler; Ronald Frank; Toby J Gibson; David Gloriam; Larry Gold; Friedrich W Herberg; Henning Hermjakob; Jörg D Hoheisel; Thomas O Joos; Olli Kallioniemi; Manfred Koegl; Manfred Koegll; Zoltán Konthur; Bernhard Korn; Elisabeth Kremmer; Sylvia Krobitsch; Ulf Landegren; Silvère van der Maarel; John McCafferty; Serge Muyldermans; Per-Ake Nygren; Sandrine Palcy; Andreas Plückthun; Bojan Polic; Michael Przybylski; Petri Saviranta; Alan Sawyer; David J Sherman; Arne Skerra; Markus Templin; Marius Ueffing; Mathias Uhlén
Journal:  Nat Methods       Date:  2007-01       Impact factor: 28.547

5.  Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display.

Authors:  M He; M Menges; M A Groves; E Corps; H Liu; M Brüggemann; M J Taussig
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

Review 6.  Human antibodies as next generation therapeutics.

Authors:  M A van Dijk; J G van de Winkel
Journal:  Curr Opin Chem Biol       Date:  2001-08       Impact factor: 8.822

7.  De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods.

Authors:  Changshou Gao; Shenlan Mao; Francesca Ronca; Sufei Zhuang; Vito Quaranta; Peter Wirsching; Kim D Janda
Journal:  J Immunol Methods       Date:  2003-03-01       Impact factor: 2.303

8.  A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma.

Authors:  M J Verhaar; K A Chester; P A Keep; L Robson; R B Pedley; J A Boden; R E Hawkins; R H Begent
Journal:  Int J Cancer       Date:  1995-05-16       Impact factor: 7.396

9.  Selection of scFvs specific for HBV DNA polymerase using ribosome display.

Authors:  Myung-Shin Lee; Myung-Hee Kwon; Kyongmin Hwang Kim; Ho-Joon Shin; Sun Park; Hyung-Il Kim
Journal:  J Immunol Methods       Date:  2004-01       Impact factor: 2.303

10.  Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display.

Authors:  Achim Rothe; Anne Nathanielsz; Ralf J Hosse; Frank Oberhäuser; Elke P Strandmann; Andreas Engert; Peter J Hudson; Barbara E Power
Journal:  J Biotechnol       Date:  2007-05-24       Impact factor: 3.307

View more
  2 in total

1.  Development of a novel anti-HER2 scFv by ribosome display and in silico evaluation of its 3D structure and interaction with HER2, alone and after fusion to LAMP2B.

Authors:  Fatemeh Salimi; Mehdi Forouzandeh Moghadam; Masoumeh Rajabibazl
Journal:  Mol Biol Rep       Date:  2018-09-17       Impact factor: 2.316

2.  Selection of single-chain variable fragments specific for Mycobacterium tuberculosis ESAT-6 antigen using ribosome display.

Authors:  Shahrzad Ahangarzadeh; Mojgan Bandehpour; Bahram Kazemi
Journal:  Iran J Basic Med Sci       Date:  2017-03       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.